Euretos is located in Utrecht, Netherlands on Yalelaan 1. Euretos is rated 3 out of 5 in the category biotechnology in Netherlands. Euretos provides AI driven contract research services and cloud access to the Euretos AI Platform to enable preclinical discovery & clinical validation of targets, biomarkers and indications. Our applications and services give researchers fundamental and novel insights into the systems biological, molecular mechanisms that drive phenotypes, disease pathologies, toxicities and drug response. Euretos uses Machine Reading to semantically integrate over 275 public life sciences data and textual sources to provide the largest knowledge base where multi omics data is interlinked to literature, patents, experimental and clinical evidence. State-of-the-art Machine & Deep Learning algorithms for cell type deconvolution, co-expression prediction and target perturbation analysis leverage this unique knowledge base to create highly insightful molecular disease models. These unique assets enable (pre)clinical researchers to take a translational systems biology approach by connecting multi-omics interactions, through cell-type involvement, to downstream pathways, phenotypes and disease pathologies. Euretos has taken a unique approach as we are the only AI vendor in the drug development area: - That is a pure products & service provider without developing their own pipeline - That uses Machine Reading for data integration which provides a very significant increase in data quality - To have developed an end-user cloud application for biological researchers (i.e. non-data scientists) therefore impacting all levels of the R&D organisation - With a singular focus on systems biology and molecular level insight into diseases and the biological effects of drug therapies
Company size
11-50 employees
Accessibility
Wheelchair-accessible entrance